Barinthus Biotherapeutics (BRNS)
NASDAQ: BRNS
· Real-Time Price · USD
1.26
0.02 (1.61%)
At close: Aug 18, 2025, 10:57 AM
Barinthus Biotherapeutics Income Statement
Financials in USD. Fiscal
year is
January - December.
Fiscal Year | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 |
Period Ending | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 |
Revenue | n/a | -9.17M | 14.97M | n/a | n/a | 5.37M | n/a | 334K | 468K | 6.46M | 6.17M | 17.06M | 15.02M | -1K | 19K | 35K | 215K |
Cost of Revenue | n/a | 1.42M | 1.49M | 1.47M | 1.43M | 1.45M | 1.47M | 1.62M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Gross Profit | n/a | 2.9M | 13.63M | -1.47M | -1.43M | 3.92M | -1.47M | -1.29M | 468K | 6.46M | 6.17M | 17.06M | 15.02M | -1K | 19K | 35K | 215K |
Operating Income | -20.6M | -23.39M | -9.38M | -18.29M | -16.91M | -19.99M | -16.11M | -26.34M | -21.48M | -26.04M | 7.24M | 13.23M | 654K | -16.67M | -5.54M | -16.84M | -6.17M |
Interest Income | 556K | 637K | 631K | 635K | 775K | 575.97K | 196K | 522K | 1.59M | 1.32M | 1.03M | 669K | 83K | n/a | n/a | n/a | 2K |
Pretax Income | -19.68M | -20.59M | -8.13M | -16.95M | -15.56M | -18.11M | -14.71M | -24.96M | -18.74M | -23.18M | 7.55M | 14.77M | 1.71M | -15.14M | -4.58M | -15.97M | -15.45M |
Net Income | -19.65M | -20.53M | -8.11M | -16.93M | -15.49M | -17.29M | -14.07M | -23.8M | -18.18M | -21.19M | 8.24M | 15.69M | 2.6M | -15.11M | -4.56M | -15.93M | -15.27M |
Selling & General & Admin | 12.64M | 3.06M | 13.42M | 5.84M | 5.99M | 13.73M | 961K | 13.13M | 12.14M | 20.31M | -10.81M | -6.45M | 3.66M | 9.79M | 1.18M | 12.37M | 1.78M |
Research & Development | 7.99M | 6.22M | 10.53M | 10.97M | 11.12M | 5.83M | 13.94M | 12.98M | 8.66M | 12.1M | 10.47M | 8.89M | 9.65M | 5.67M | 3.41M | 3.63M | 3.65M |
Other Expenses | -27K | 11.79M | 398K | 20K | 389K | 540K | 1.21M | 559K | n/a | n/a | n/a | 553K | n/a | n/a | 0.00 | -3K | n/a |
Operating Expenses | 20.6M | 25.39M | 24.35M | 17.32M | 15.68M | 19.99M | 14.9M | 26.67M | 21.95M | 32.4M | -347K | 3M | 13.32M | 15.46M | 4.6M | 16M | 5.43M |
Interest Expense | 13K | 12K | 17K | 12K | 12K | 7.06K | 7K | 14K | n/a | 22.16K | n/a | 7K | 74K | 18K | n/a | n/a | 2.65M |
Selling & Marketing Expenses | n/a | n/a | n/a | -1.36M | n/a | 118K | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Cost & Expenses | 20.6M | 17.66M | 24.35M | 18.98M | 16.91M | 26M | 14.9M | 26.67M | 20.8M | 32.4M | -347K | 3M | 13.32M | 15.46M | 4.6M | 16M | 5.43M |
Income Tax Expense | -22K | 3K | -3K | -7K | -631K | -827K | -603K | -1.14M | -516K | -2.02M | -674K | -915K | -863K | 32K | -7K | 12K | -65K |
Shares Outstanding (Basic) | 40.27M | 39.35M | 39.42M | 39.04M | 38.77M | 38.6M | 38.53M | 38.41M | 38.01M | 37.68M | 37.25M | 37.2M | 37.19M | n/a | 34.84M | 24.9M | 34.06M |
Shares Outstanding (Diluted) | 40.27M | 39.35M | 39.42M | 39.04M | 38.77M | 38.6M | 38.53M | 38.41M | 38.01M | 37.68M | 38.16M | 38.17M | 38.35M | n/a | 34.84M | 24.9M | 34.06M |
EPS (Basic) | -0.49 | -0.51 | -0.21 | -0.43 | -0.4 | -0.45 | -0.37 | -0.62 | -0.48 | -0.56 | 0.22 | 0.42 | 0.07 | n/a | -0.13 | -0.64 | -0.45 |
EPS (Diluted) | -0.49 | -0.51 | -0.21 | -0.43 | -0.4 | -0.45 | -0.37 | -0.62 | -0.48 | -0.56 | 0.22 | 0.41 | 0.07 | n/a | -0.13 | -0.64 | -0.45 |
EBITDA | -17.63M | -19.15M | -6.64M | -15.47M | -14.12M | -16.67M | -13.23M | -23.65M | -17.52M | -21.1M | 8.66M | 15.77M | 2.75M | -14.8M | -4.49M | -15.87M | -12.71M |
EBIT | -19.67M | -20.58M | -8.12M | -16.94M | -15.54M | -18.1M | -14.71M | -24.95M | -18.74M | -22.28M | 7.48M | 14.78M | 1.78M | -15.12M | -4.58M | -15.97M | -12.8M |
Depreciation & Amortization | 2.03M | 1.43M | 1.49M | 1.47M | 1.43M | 1.45M | 1.47M | 1.3M | 1.23M | 1.18M | 1.18M | 983.37K | 960.47K | 321K | 84.62K | 103.8K | 92.32K |